Criteria

Acute immune-mediated reactions

These occur within 24 hours of transfusion, and often during the transfusion itself.

Acute haemolytic transfusion reactions, depending on severity, may be characterised by:[3]

  • Pain along the infused extremity

  • Abdominal, chest, or back pain, which can accompany generalised symptoms

  • Haemoglobinuria, which can manifest as red urine

  • Progression to hypotension, renal failure, and disseminated intravascular coagulation (DIC) in severe cases

  • Positive direct antiglobulin test

  • Evidence of haemolysis upon visual inspection of the plasma.

Febrile non-haemolytic transfusion reactions are a diagnosis of exclusion. They are characteristically:

  • Associated with fever, specifically a rise in temperature of at least 1°C (1.8°F) above 37°C (98.6°F) for which no other cause is identifiable

  • Benign, although they initially may be indistinguishable from the onset of an acute haemolytic transfusion reaction

  • Not associated with evidence of haemolysis.

Allergic reactions are diagnosed clinically. They are characterised by:

  • Pruritus, flushing, and dyspnoea

  • Symptoms within minutes of the initiation of transfusion

  • Urticaria that evolves; angio-oedema develops less commonly

  • Lack of evidence of haemolysis on lab tests

  • Anaphylaxis - a serious, potentially life-threatening, systemic allergic reaction - which may follow.[5] Anaphylaxis is generally rapid in onset, with variable signs and symptoms, and typically affects two or more body systems (e.g., cutaneous, respiratory, cardiovascular).[5] However, atypical presentations may only appear to affect a single system (e.g., isolated hypotension).[5]​ There may be features of respiratory compromise (e.g., dyspnoea, wheezing, stridor, hypoxaemia, reduced peak expiratory flow) and/or cardiovascular compromise or associated end-organ dysfunction (e.g., hypotension, hypotonia/collapse, syncope, incontinence).[5]​ Gastrointestinal symptoms may also be present (e.g., cramping abdominal pain, vomiting, diarrhoea).[5]​ It should be noted that typical cutaneous features of anaphylaxis (e.g., urticaria, flushing, pruritus, angio-oedema) are not always present.[5]​ The diagnosis of anaphylaxis is clinical, based on the clinical history and the signs and symptoms present during the event.[5]​ ​In cases where anaphylaxis occurs, testing for anti-IgA levels and serum tryptase levels should be performed (without delaying emergency management) to aid with post-acute confirmation of the diagnosis.[5][32]​​ See Anaphylaxis (Diagnostic criteria).

Transfusion-related acute lung injury (TRALI) is characterised by:[38]

  • New onset of acute lung injury during or within 6 hours of transfusion of plasma-containing blood product(s)[7][8]​​

  • Absence of a temporal relationship to an alternative risk factor for acute lung injury (such as sepsis, aspiration pneumonitis, or pulmonary contusion)[8]

  • Acute lung injury

  • Criteria for acute lung injury, which include acute onset of symptoms, absence of circulatory overload, bilateral pulmonary infiltrates on chest x-ray, and hypoxaemia as demonstrated by PaO2/FIO2 <300 mmHg.[8]

Delayed immune-mediated reactions

These usually occur days to weeks from the transfusion event.

Delayed haemolytic transfusion reactions are characterised by:[3]

  • Fever or anaemia

  • Jaundice (in some patients)

  • Extravascular haemolysis (rarely causes acute renal failure or DIC)

  • Diagnosis supported by a new positive direct antiglobulin test and/or positive antibody screen, elevated LDH, and bilirubin.

Transfusion-associated graft-versus-host disease occurs 8 to 10 days after a transfusion and is characterised by:[9]

  • Maculopapular rash

  • Fever

  • Diarrhoea

  • Bone marrow aplasia and rapid progress towards death in some patients

  • Occurrence in immunocompromised patients

  • Skin biopsy of the affected area, which is diagnostic.

Post-transfusion purpura are characterised by:

  • Bleeding from mucous membranes, gastrointestinal tract, and urinary tract

  • Associated thrombocytopenia, usually severe (less than 10 x 10⁹/L)[22]

  • Platelet antibody screen, which confirms diagnosis.

Use of this content is subject to our disclaimer